Influence of polymorphic N-acetyltransferases on non-malignant spontaneous disorders and on response to drugs

Current Drug Metabolism

Volumn 9, Issue 6, 2008, Pages 532-537

  Ladero, J M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Acetylator polymorphism; Alzheimer's disease; Diabetes mellitus; Drug response; N acetyl transferases; Parkinson's disease; Rheumatoid arthirtis autoimmune diseases; Side effects

Indexed keywords

ACYLTRANSFERASE; ACYLTRANSFERASE 1; ACYLTRANSFERASE 2; DAPSONE; DOXYCYCLINE; HYDRALAZINE; ISONIAZID; NITRAZEPAM; PHENELZINE; PROCAINAMIDE; RIFAMPICIN; SALAZOSULFAPYRIDINE; SULFONAMIDE; TRANSFERASE;

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BEHCET DISEASE; DEGENERATIVE DISEASE; DIABETES MELLITUS; DRUG ACETYLATION; DRUG BLOOD LEVEL; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG RESPONSE; ENDOMETRIOSIS; ENTERITIS; ENZYME ACTIVITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOPATHOGENESIS; LUPUS LIKE SYNDROME; NEUROPATHOLOGY; PARKINSON DISEASE; PENETRANCE; PERIODONTAL DISEASE; PHARMACOGENETICS; REVIEW; RHEUMATOID ARTHRITIS; SKIN ALLERGY; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ACETYLATION; ACETYLTRANSFERASES; ANIMALS; AUTOIMMUNE DISEASES; HUMANS; NEURODEGENERATIVE DISEASES; PHARMACEUTICAL PREPARATIONS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 47749083130     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920008784892038     Document Type: Review

References (83)

1. Upton, A.; Smelt, V.; Mushtaq, A.; Aplin, R.; Johnson, N.; Mardon, H. and Sim, E. (2000) Biochim. Biophys. Acta, 1524 (2-3), 143-148.
2. Evans, D.A.P. (1992) in Pharmacogenetics of Drug Metabolism (Kalow, W. Ed.), Pergamon Press, New York, pp 95-178
3. Weber, W.W. (1987) The acetylator genes and drug response, Oxford University Press, New York
4. Steventon, G.B.; Heafield, M.T.E.; Sturman, S.; Waring, R.H. and Williams, A.C. (1990) Neurology, 40 (7), 1095-1098.
5. Ladero, J.M.; Barquero, M.S.; Coria, F.; Molina, F.J.; Jiménez-Jiménez, F.J. and Benítez, J. (1993) Eur. J. Med., 2 (5), 281-283.
6. Rocha, L.; Garcia, C.; de Mendonça, A.; Gil, J.P.; Bishop D.T. and Lechner, M.C. (1999) Pharmacogenetics, 9 (1), 9-15.
7. Johnson, N.; Bell, P.; Jonovska, V.; Budge, M. and Sin, E. (2004) BMC Med. Genet., 17 (5), 6
8. Guo, W.C.; Lin, G.F.; Zha, Y.L.; Lou, K.J.; Ma, Q.W. and Shen, J.H. (2004) Acta Pharmacol. Sin., 25(9), 1112-1117.
9. Ladero, J.M.; Jiménez, F.J.; Benítez, J.; Fernández-Gundín, M.J.; Martínez, C.; Llerena, A.; Cobaleda, J. and Muñon, J.J. (1989) Eur. J. Clin. Pharmacol., 37(4), 391-393.
10. van der Walt, J.M.; Martin, P.R.; Scott, W.K.; Zhang, F.; Nance, M.A.; Watts R.L.; Hubble, J.P.; Haines, J.L.; Koller, W.C.; Lyons, K.; Pahwa, R,; Stern, M.B.; Colcher, A.; Hiner, B.C.; Jankovic, J.; Ondo, W.G.; Allen, F.H.; Goetz, C.G.; Small, G.W.; Mastaglia, F.; Roses, A.D.; Stajich,. J.M.; Booze, M.W.; Fujiwara, K.; Gibson, R,A.; Middleton, L.T.; Scott, B.L.; Pericak-Vance, M.A. and Vance, J.M. (2003) Neurology, 60 (7), 1189-1191
11. Bandmann, O.; Vaughan, J.R.; Holmans, P.; Marsden, C.D. and Wood, N.W. (2000) Mov. Disord., 15 (1), 30-35.
12. Nicboll, D.J.; Bennett, P.; Hiller, L.; Bonifati, V.; Vanacore, N.; Fabbrini, G.; Marconi, R.; Colosimo, C.; Lamberti, P.; Stocchi, F.; Bonuccelli, U.; Vieregge, P.; Ramsden, D.B.; Meco, G. and Williams, A.C. (1999) Neurology, 53 (7), 1382-1383
13. Agundez, J.A.G.; Jiménez-Jiménez, F.J.; Luengo, A.; Molina, J.A.; Ortí-Pareja, M.; Vázquez, A.; Ramos, F.; Duarte, J.; Coria, F.; Ladero, J.M.; Alvarez-Cermeño, J.G. and Benítez, J. (1998) Neurology, 51 (6), 1597-1592.
14. Chaudhary, S.; Behari, M.; Dihana, M,; Swaminath, P.V.; Govindappa, S.T.; Jayaram, S.; Singh, S.; Mutane, U.B. and Juyal, R.C. (2005) Pharmacogenetics Genomics, 15 (10), 731-735.
15. Bialecka, M,; Klodowska-Duda, G.; Honczarenko, K.; Gawronska-Szklarz, B.; Opals, G.; Safranow, K. and Drozdzik M. (2007) Parkinson. Relat. Disord., 13 (4), 224-229.
16. Chan, D.K.Y.; Lam, M.K.P.; Wong, R.; Hung, W.T. and Wilcken, D.E.L. (2003) Neurology, 60 (6), 1002-1005.
17. Maraganore, D.M.; Farrer, M.J.; Ardí, J.A.; McDonnell. S.K.; Schaid, D.J. and Rocca, W.A. (2000) Mov. Disord., 15 (4), 714-719.
18. Harbangi, B.S.; Oostra, B.A.; Heutink, P.; van Duijn, C.M.; Hofman, A. and Breteler, M.M. (11999) J. Neurol. Neurosurg. Psychiatry, 67 (4), 518-520.
19. Borlak, J. and Reamon-Buettner, S.M. (2006) BMC Med. Genet., 7, 58
20. Scott, W.K.; Nance, M.A.; Watts, R.L.; Hubble, J.P.; Koller, W.C.; Lyons, K.; Pahwa, R.; Stern, M.B.; Colcher, A,; Hiner, B.C.; Jankovik, J.; Ondo, W.G.; Allen, F.R.; Goetz, C.G.; Small, G.W.; Masterman, D.; Mastaglia, F.; Laing, N.G.; Stajich. J.M.; Slotterbeck, B.; Booze, M.W.; Ribble, R.C.; Rampersaud, E.; West, S.G.; Gibson, R.A.; Middleton, L.T.; Roses, A.D.; Haines, J.L.; Scott, B.L.; Vance, J.M. and Pericak-Vance, M.A. (2001) JAMA, 286 (18), 2239-2244.
21. Kumana, W.K.; Chan, M.M.; Wong, K.L.; Wong, R.W.; Kou, M. and Lauder, I.J. (1990) Clin. Pharmacol. Ther., 48 (2), 208-213.
22. Ong, M.L.; Maur, T.G.; Veerapen, K.; Fitzgerald, D.; Wang, F.; Manivasagar, M. and Bosco, J.J. (1990) Br. J. Rheumatol., 29 (6), 462-464.
23. Zschieschang, P.; Hiepe, F.; Gromnica-Ihle, E.; Roots, I. and Cascorbi, I. (2002) Pharmacogenetics, 12 (7), 559-563.
24. Rychlik-Sych, M.; Skretkowick, J.; Gawronska-Szklarz, B.; Górnik, W.; Sysa-Jedrzejowska, A. and Skretkkowicz-Szarmach, K. (2006) Pharmacol. Rep., 58 (1), 22-29
25. Pullar, T.; Hunter, J.A. and Capell, H.A. (1985) Ann. Rheum. Dis., 44(12), 831-837.
26. Ladero, J.M.; Andrés, M.P.; Bañares, A.; Fernández, B.; Hernández, C. and Benítez, J. (1993) Eur. J. Clin. Pharmacol., 45 (3), 279-281.
27. Astbury, C.; Beyeler, C. and Bird, H.A. (1995) Rheumatol. Int., 14 (6), 257-260.
28. Pawlik, A.; Ostanek, L.; Brzosko, I.; Gawroska-Szklarz, B.; Brzosko, M. and Dabrowska-Zamojcin, E. (2002) Clin. Pharmacol. Ther., 72 (3), 319-325.
29. Pawlik, A.; Ostanek, L.; Brzosko, I.; Brzosko, M.; Dabrowska-Zamojcin, E. and Gawroska-Szklarz, B. (2004) Clin. Exp. Rheumatol., 22 (1), 99-102.
30. Kumagai, S.; Komada, F.; Kits, T.; Morinobu, A.; Ozaki, S.; Ishida, H.; Sano, H.; Matsubara, T. and Okamura, T, (2004) Pharm Res., 21 (2), 324-329.
31. Aynacioglu, A.S.; Bozkurt A.; Nacak, M.; Kortunny, S.; Tune, R.; Dincel, A. and Kayaalp, S.O. (2001) Eur. J. Clin. Pharmacol., 57 (9), 659-662.
32. Tamer, L.; Tursen, U.; Eskandari, G.; Ates, N.A.; Ercan, B.; Yildirim, H. and Atik, U. (2005) Clin. Exp. Dermatol., 30 (1), 56-60.
33. Ladero, J.M.; Jiménez, L.C.; Fernández, M.J. and Robledo, A. (1988) Eur. J. Clin. Pharmacol., 34 (3) 307-308.
34. Skretkowicz, K.; Skretkowicz, J.; Gawronska-Szklark, B.; Górnik, W.; Rychlik-Sych, M. and Sysa-Jedrzejowska, A. (2005) Eur. J. Clin. Pharmacol., 60 (11), 773-778.
35. Ladero, J.M.; Ruiz-Lasa, J.I. and Cano, F. (1983) N. Arch. Fac. Med Madrid, 41 (2), 79-81.
36. Siegmund, W.; Franke, G.; Meng, S.; Gothe, P. and Meng, W, (1988) Int. J. Chn. Pharmacol. 7her. Toxicol., 26 (8), 397-399.
37. Ladero, J.M.; Arroyo, R.; de Andrés, C.; Jiménez-Jiménez, F.J.; Molina, J.A.; Varela de Seijas, E.; Jiménez-Roldán, S. and Benítez, J. (1994) Acta Neural. Scand., 89 (2), 102-104.
38. Jiménez-Nieto, LC.; Ladero, J.M.; Fernández-Gundía, M.J. and Robledo, A. (1989) Dermatológica, 178 (3), 136-137.
39. Azad-Khan, A.K.; Nurazzaman, M. and Truelove, S.C. (1983) J. Med. Genet., 20 (1), 30-36.
40. Ladero, J.M.; Serrano, M.; Agúndez, J.A.G.; Lozano, L.; Olivera, M.; Benítez, J. and Díaz-Rubio, M. (2002) Revista ACAD, 18 (3), 102-104.
41. Ricart, E.; Taylor, W.R.; Loftus, E.V.; O'Kane, D.; Weinshilboum, R.M.; Tremaine, W.J.; Harmsen, W.S.; Zinsmeister, A.R. and Sandborn, W.J. (2002) Am. J. Gastroenterol., 97 (7), 1763-1678
42. Cheng M.; Ma, B.; Chen, B.; Guo, Q.; Li, J.; Ye, M. and Hu, Z. (2007) Can. J. Gastroenterol., 21 (3), 155-158.
43. Mahid, S.S.; Colliver, D.W.; Crawford, N.P.; Martini, B.D.; Dol, M.A.; Hein, D.W.; Cobbs, G.A.; Petras, R.E. and Galandiuk, S. (2007) BMC Med. Genet., 8, 28.
44. García-Martín, E.; Mendoza, J.L.; Martínez, C.; Taxonera, C.; Urcelay, E.; Ladero, J.M.; de la Concha, E.G.; Díaz-Rubio, M. and Agúndez J.A. (2006) World J. Gastroenterol., 12 (4), 615-620.
45. Bonisolli, L.; Pontiroli, A.E.; De Pasqua, A.; Calderara, A.; Maffi, P.; Gallus, G.; Radaelli, G. and Pozza, G. (1985) Acta Diabetol. Lat., 22 (4), 305-315.
46. Stryjek-Kaminska, D.; Malczewski, B.; Kopec, A. and Rowinska-Marcinska, K. (1988) Acta Diabetol. Lat., 25 (1) 41-48.
47. Madácsy, L.; Szórády, I.; Sánta, A.; Barkai, L. and Vámosi, I. (1992) Child Nephrol. Urol., 12 (4), 192-196.
48. Mrozikiewicz, P.M.; Drakoulis, N. and Roots, I. (1994) Clin. Pharmacol. Ther., 56 (6 Pt1), 626-634.
49. Korpinen, E.; Groop, P.H.; Rautio, A.; Madácsy, L.; Reunanen, A.; Vaarala, O. and Akerblom, H.K. (1999) Pharmacogenetics, 9 (5), 627-633.
50. Suhardjono, D.; Boutagy, J. and Shenfield, G.M. (1986) Br. J. Clin. Pharmacol., 22 (4), 401-408.
51. McLaren, E.H.; Burden, A.C. and Moorhead, P.J. (1977) Br. Med. J., 2 (6082), 291-293.
52. Burrows, A.W.; Hockaday, T.R.; Mann, J.I. and Taylor, J.G. (1978) Br. Med. J., 1 (6107), 208-210.
53. Shenfield, G.M.; McCann, V.J. and Tjokresetio, R. (1982) Diabetologia 22 (6), 221-224.
54. Ladero, J.M.; Arrojo, A.; de Salamanca, R.E.; Gómez, M.; Cano, F. and Alfonso, M. (1982) Ann. Clin. Res., 14 (4), 187-189.
55. Evans, D.A.; Paterson, S.; Francisco, P. and Alvarez, G. J. Med. Genet., 22 (6), 479-483.
56. Irshaid, Y.; al-Hadidi, H.; Abuirjeie, M.; Latif, A.; Sartawi, O. and Rawashdeh, N. (1992) Eur. Clin. Pharmacol., 43 (6), 621-623.
57. El-Yazigi, A.; Johansen, K.; Raines, D.A. and Dossing, M. (1992) J. Clin. Phamacol., 32 (10), 905-910.
58. Agúndez, J.A.G.; Menaya, J.G.; Tejeda, R.; Lago, F.; Chávez, M. and Benítez, J. (1996) Pharmacogenetics, 6 (5), 465-472.
59. Yalin, S.; Hatungil, R.; Tamer, L.; Ates, NA; Dogruer, N.; Yildirim, H.; Karakas, S. and Atik, U. (2007) Cell Biochem. Funct., 25 (4), 407-411.
60. Neugebauer, S.; Baba, T.; Watanabe, T.; Ishizaki, T. and Kurokawa, K. (1994) Diabet Med., 11 (8), 783-788.
61. Baranova, H.; Canis, M.; Ivaschenko, T.; Albuisson, E.; Bothorishvilli, R.; Baranov, V.; Malet, P. and Bruhat, M.A. (1999) Mol. Hum. Reprod., 5 (7), 636-641.
62. Guo, S-W. (2006) Eur. J. Obstetr. Gynecol., 124 (2), 134-143.
63. Ladero, J.M.; Fernández, M.J. and Palmeiro, R. (1987) Rev. Clin. Esp., 181 (1), 24-25.
64. Ladero, J.M.; E. De Salamanca, R. and Chinarro, S. (1981) Arch. Dermatol. Res., 270 (2), 171-173.
65. Meisel, P.; Timm, R.; Sawaf, H.; Fanghänel, J.; Siegmund, W. and Kocher, T. (2000) Arch. Toxicol., 74 (6), 343-348.
66. Kocher, T.; Sawaf, H.; Fanghänel, J.; Timm, R. and Meisel, P. (2002) J. Clin. Periodoltol., 29 (1), 21-27.
67. Ladona, M.G.; Izquierdo-Martínez, M.; Posada de la Paz, M.; de la Torre, M.; Ampurdanés, C.; Segura, J. and Sanz, E.J. (2001) Environ. Health Perspect., 109 (4), 369-375.
68. Ladero, J.M. (2002) Environ. Health Perspect., 110 (1), A14.
69. Hirvonen, A.; Saarikoski, S.T.; Linnainmaa, K.; Koskinen, K.; Husgafvel-Pursianen, K.; Mattson, K. and Vainio, H. (1996) J. Natl. Cancer Inst., 88 (24), 1853-1856.
70. Wikman, H.; Piirilä, P.; Rosenberg, C.; Luukkonen, R.; Kääriä, K.; Norppa, H.; Vainio, H. and Hirvonen, A- (2002) Pharmacogenetics, 12 (3), 227-233.
71. Meisel, P. (2002) Pharmacogenomics, 3 (3), 349-366.
72. Le Louët, H.; Ruivart, M.; Bierling, P.; Duche, J.C. and Godeau, B. (1999) Am. J. Hematol., 62 (4), 251-252.
73. Swift, C.G.; Hewick, D.S.; Ogg, G. and Stevenson, I.H. (1980) Br. J. Clin. Pharmacol., 9 (3), 312P-313P.
74. Rose, S. (1982) J. Clin. Psychopharmacol., 2 (3), 161-164
75. Shepherd, A.M.; McNay, J.L.; Ludden, T.M.; Lin, M.S. and Musgrave, G.E. (1981) Hypertension, 3 (5), 580-585.
76. Colmenero, J.D.; Fernández-Gallardo, L.C.; Agúndez, J.A.; Sedeño, J.; Benítez, J. and Valverde, E. (1994) Antimicrob. Agents Chemother., 38 (12): 2798-2802.
77. Tanaka, E.; Taniguchi, A.; Urano, W.; Nakajima, H.; Matsuda, Y.; Kitamura, Y.; Saito, M.;.Yamanaka, H.; Saito, T. and Kamatani, N. (2002) J. Rheumatol., 29 (12, 2492-2499.
78. Taniguchi, A.; Urano, W.; Tanaka, E.; Furihata, S.; Kamitsujt S.; Inoue, E.; Yamanaka, M.; Yamanaka, H. and Kamatani, N. (2007) Pharmacogenet. Genomics, 17 (6), 383-390.
79. Bing, R.F.; Russell, G.I.; Thurston, H. and Swales, J.D. (1980) Br. Med. J., 281 (6236), 353-354.
80. Adams, L.E.; Balakrishnan, K.; Roberts, S.M. Belcher, R.; Mongey, A.B.; Thomas, T.J. and Hess, E.V. (1993) Lupus, 2 (2), 99-98.
81. Wolkenstein, P.; Carriere, V.; Cnarue, D.; Bastuji-Garin, S.; Revuz, J.; Roujeau, J.C.; Beaune, P. and Bagot, M. (1995) Pharmacogenetics, 5 (4), 255-258.
82. Adedoyin, A.; Stiff, D.D.; Smith, D.C.; Romkes, M.; Bahnson, R.C.; Day, R.; Hofacker, J.; Branch, R.A. and Trump, D.L. (1998) Cancer Chemother. Pharmacol., 41 (2), 133-139.
83. Chung, J.G.; Chang, H.L.; Lin, W.C.; Yeb, F.T. and Hung, C.F. (1999) J. Appl. Toxicol., 19 (1), 1-6.